For laboratory research use only - not for human consumption

Hub · Research Peptides in Perth

NAD+ in Perth

NAD+ is a dinucleotide (two linked nucleotide units) and a coenzyme (a small molecule that takes part in enzyme reactions), rather than an amino-acid chain; its oxidized and reduced forms carry electrons through cellular reactions. For NAD+ in Perth, the Form Laboratories catalogue separates this biochemical identity from batch-specific charge, salt and water content, while the cited literature explains redox (reduction and oxidation: linked processes in which electrons are gained and lost) chemistry and enzymes that consume NAD+.

Published 2026-10-02Updated 2026-10-02Written by Form Laboratories research team9 min read

Think of a rechargeable battery: you can charge it, empty it and charge it again without changing which battery it is. NAD+ in Perth starts with a similar distinction between chemical states, although NAD+ is a coenzyme, not a peptide. That category correction earns its place in the Perth research peptides hub: nearby catalogue entries need not share the same molecular structure.

The battery picture has a limit worth keeping in mind. NAD+ and its reduced partner NADH exchange electrons in cell chemistry; they are not tiny electrical cells. As the story unfolds, the name separates into three questions: what molecule is being discussed, what reaction involves it, and what a particular batch report establishes. Keeping those questions apart makes the chemistry much easier to follow.

Key facts

Key facts for NAD+ in Perth: What It Is, and Why It Is Not a Peptide
Common nameNAD+
Full nameNicotinamide adenine dinucleotide
ClassOxidized pyridine dinucleotide coenzyme
Is it a peptide?No; nucleotide-based coenzyme, without an amino-acid sequence
CAS53-84-9 — catalogue identity record
Molecular formulaC21H27N7O14P2 — catalogue convention
Molecular weight663.43 g/mol — Form Laboratories spec sheet
Reduced counterpartNADH
Form noteCharge state, salt and hydration: batch lab report determines supplied form
Sirtuin co-substrate recordImai and colleagues; Nature (2000)
October classification searchNo individual entry for nad+, nicotinamide adenine dinucleotide or nadh in F2026L01327; checked 1 October 2026 UTC
Storage2-8 C; keep dry, shield from light — catalogue
Form Laboratories catalogueTGA peptide definition, 13 April 2026

Is NAD+ a peptide?

NAD+ is not a peptide: its structure is a dinucleotide coenzyme, rather than amino acids joined in a chain. The dinucleotide’s two nucleotide units are linked, and the coenzyme takes part in reactions driven by enzymes. The Form Laboratories catalogue calls NAD+ an “Oxidized pyridine dinucleotide coenzyme”. Those words describe chemical identity, not a result. The distinction matters because a peptide sequence cannot identify this molecule. A familiar catalogue category can hold different kinds of research material, but a shared setting does not turn their structures into the same thing.

The NAD+ research guide provides the longer literature trail behind the name. For a peptide, the order of amino acids is central to describing its identity. For NAD+, the useful starting point is the dinucleotide structure and the redox state. A comparison between a peptide and a coenzyme therefore begins with their building blocks. Neither a city name nor a storage label supplies the missing chemistry.

Nature, 2000Trends in Biochemical Sciences, 2007Nature Reviews Molecular Cell Biology, 2021

Evidence limits

What can this NAD+ evidence establish?

The NAD+ sources used here establish molecular and pathway context, not a demonstrated human outcome from a supplied batch. Imai and colleagues studied Sir2 enzyme activity in Nature in 2000. Belenky and colleagues reviewed NAD metabolism in Trends in Biochemical Sciences in 2007. Covarrubias and colleagues surveyed cellular processes in Nature Reviews Molecular Cell Biology in 2021. The review discusses a broad literature; calling it a review of pathways does not mean that every study it cites uses the same model. This article draws no personal-outcome conclusion from that collection.

The evidence boundary is practical. An enzyme experiment can explain a reaction. A review can organise what many experiments suggest. A batch document can identify the material examined by a laboratory. Those are different jobs, so this page keeps them separate. No entry in the citation list is presented as a test of the catalogue lot. Reading a familiar molecule name across all three records does not make their subjects interchangeable.

Form Laboratories identity recordCovarrubias et al., 2021

What is NAD+ made from?

NAD+ consists of two joined nucleotide units, with its nicotinamide part involved in electron-transfer chemistry. The full name is nicotinamide adenine dinucleotide. The catalogue records CAS 53-84-9, formula C21H27N7O14P2 and molecular weight 663.43 g/mol for its identity convention. A CAS number is a chemical identifier; a formula counts the atoms represented by that convention. Neither describes an amino-acid order. The catalogue also notes that charge state and supplied form can change formula and mass conventions. That is why the identity record and the batch report must be read together.

NAD+ has a named oxidized state as well as a recorded molecular identity. The catalogue’s class line puts both in the same description. That helps distinguish two questions: which chemical is named, and which form is documented for a lot. A broad label such as research compound answers neither by itself. The full name, registry identifier and supplied-form note each add a different piece to that identity picture.

NAD+ catalogue research notesCovarrubias et al., 2021

How are NAD+ and NADH related?

NAD+ is the oxidized member of the pair, while NADH is its reduced counterpart after accepting a hydride, a hydrogen species carrying electrons. Redox means reduction and oxidation. Covarrubias and colleagues describe this chemistry in their 2021 review. The NAD+/NADH notation names related chemical states, rather than two unrelated substances. The battery opening is useful only at that level. A cell has enzyme-driven reactions, not a battery charger, and the shorthand does not describe what research material would do for a person.

The catalogue treats the pair as an electron-transfer reference in energy metabolism. Following NAD+ through a redox reaction means tracking a change of state. Following NAD+ through a consuming reaction means asking a different question about chemical breakdown. The same starting name appears in both stories, which can make them easy to blur. The redox pair explains one branch of the literature; it does not stand in for every reaction involving the molecule.

Imai et al., Nature, 2000Belenky et al., 2007Covarrubias et al., 2021

What do the NAD+ papers describe?

NAD+ research describes both electron exchange and reactions that consume the coenzyme. In Nature in 2000, Imai and colleagues identified NAD-dependent removal of acetyl groups by yeast and mouse Sir2 proteins. An acetyl group is a small chemical tag on a protein. The 2007 Trends in Biochemical Sciences review by Belenky and colleagues distinguish hydride-transfer chemistry from NAD-consuming enzymes. The 2021 Nature Reviews Molecular Cell Biology review by Covarrubias and colleagues groups consuming enzymes into sirtuins (which remove particular chemical groups from proteins), PARPs (poly(ADP-ribose) polymerases, which transfer ADP-ribose units derived from NAD+) and NADases (enzymes that break down NAD+). CD38 is an example within NADases, rather than an additional family.

These names describe distinct reactions, even though all draw on the same coenzyme. The Sir2 experiment is a clear example of enzyme chemistry: a protein, a substrate and a measured reaction. The later reviews widen that view to a network of cellular processes. That network remains biological context, not a batch performance claim.

TGA, 13 April 2026TGA/CMO, 19 June 2026TGA About the ARTG, 28 November 2024

What do the peptide advisory lists say about NAD+?

NAD+ is absent from the example lists in the TGA peptide advisory of 13 April 2026 and joint statement of 19 June 2026, searched for “NAD+” and “nicotinamide adenine dinucleotide” on 2 October 2026 UTC. The April document defines peptides through amino-acid chains; NAD+ has a different structure. That distinction explains the category boundary, but cannot determine a legal position for a particular product. A list of examples is not a complete register. The chemistry answer must therefore remain separate from any inference about supply, importation or advertising.

The Australian Register of Therapeutic Goods has a different purpose: the TGA’s About the ARTG page, dated 28 November 2024, describes it as the database of therapeutic goods that can be supplied legally. No ARTG product search is reported here. In its peptide advisory of 13 April 2026, the TGA states: “Disclaimers that a product is for ‘research use only’ does not make its supply lawful. These disclaimers alone do not: change a product’s regulatory status permit importation, or remove advertising or supply obligations.” Its peptide context must be retained; this page does not extend its class statements to a dinucleotide or treat an omitted name as clearance.

NAD+ catalogue form note and batch documentation

What does the NAD+ batch lab report settle?

The NAD+ batch lab report settles the supplied form details that a general molecule name leaves open: charge state, salt and hydration. Hydration means the water associated with the material. The Form Laboratories identity record makes those details COA-led, meaning led by the certificate of analysis for the lot. The catalogue also places assay method, purity, water content and release state with that matching document. The general formula is a starting point, not a substitute for the lot record. This is a form-identity question, quite different from reading a peptide sequence.

The guide to reading a certificate of analysis sits beside that distinction. A reader looking at the NAD+ reference material listed in the catalogue needs the matching record when interpreting the supplied form. The question is what the document states for that lot, rather than what a paper says about cellular NAD+. A formula, an assay result and a pathway diagram answer different questions, even when the same compound name heads each one.

Form Laboratories NAD+ storage recordForm Laboratories shipping page

How is the NAD+ reference stored and dispatched from Perth?

The NAD+ catalogue specifies storage at 2-8 C, with the material kept dry and protected from light. Its format is a biochemical research reference, and the product record describes freeze-dried material. Those handling facts do not make it a peptide. The shipping page for Form Laboratories in Perth says orders leave after payment has cleared and been matched, travelling within Australia through Australia Post or CouriersPlease. A tracking email follows carrier handover. Chemistry, storage and dispatch are separate parts of the record: the delivery route cannot settle molecular identity or batch composition.

The Perth dispatch notes from our Perth research peptide store describe the parcel journey. Plain outer packaging carries the order, while the lab report stays in the account, according to the shipping page. That separation is especially useful for a coenzyme whose supplied form needs its own documentation. The vial travels; the record remains attached to the order. The batch form note and the recorded storage condition keep their distinct jobs throughout that journey, without a promised arrival day replacing either one.

Comparison

A peptide and a coenzyme: compare building blocks, identity records, batch details and dated advisory examples. BPC-157 is the representative catalogue peptide; NAD+ is the dinucleotide reference.

Comparison: NAD+ in Perth: What It Is, and Why It Is Not a Peptide
CriterionBPC-157: catalogue peptideNAD+: coenzyme reference
Building blocksAmino acids connected as a peptideLinked nucleotide units
Identity recordPeptide name with its amino-acid sequenceDinucleotide identity plus oxidized state
What the lot report addsBatch assay and identity documentationSpecified salt, charge and water content
TGA peptide examplesBPC-157 occurs in April/June 2026 lists; checked 2 October 2026 UTCNo NAD+ example in those TGA lists; exact NAD+ / nicotinamide adenine dinucleotide queries, 2 October 2026 UTC

FAQ

Is NAD+ a peptide?

No. NAD+ belongs to nucleotide chemistry, whereas peptide structures link amino acids. The catalogue identifies the oxidized dinucleotide as a coenzyme. Sharing a research catalogue with peptides does not alter that molecular category.

What is the difference between NAD+ and NADH?

NADH names the electron-bearing reduced state; NAD+ names the oxidized state. The pair participates in redox reactions described by Covarrubias and colleagues. A state change explains the relationship more accurately than treating the names as unrelated molecules.

Is NAD+ named in the TGA peptide advisories?

The TGA April and June 2026 example lists contain no match for NAD+ or its full chemical name in the 2 October 2026 UTC check. That search concerns those example lists only. Their peptide statements cannot establish dinucleotide class coverage or a supply permission.

What does NAD+ do in a cell?

Cellular NAD+ accepts a hydride to become NADH, which carries and donates reducing equivalents; NAD+ also supplies reactions involving sirtuins, PARPs and NADases such as CD38. Belenky’s 2007 Trends in Biochemical Sciences review and the 2021 Covarrubias review describe that enzyme context. These are cellular roles, without a promised personal result.

What is NAD+’s CAS number?

The Form Laboratories identity sheet assigns NAD+ the CAS identifier 53-84-9. The identifier belongs beside the full chemical name. Interpreting the supplied salt and hydration still requires the report associated with the lot.

Part of

Research Peptides in Perth

What a Perth-based research-use-only peptide supplier is under Australian law, how the category is regulated and verified, and how orders travel within Australia.

Citations

3 sources
  1. Imai S et al. Nature. 2000;403:795-800.
    doi:10.1038/35001622

  2. Belenky P et al. Trends in Biochemical Sciences. 2007;32(1):12-19.
    doi:10.1016/j.tibs.2006.11.006

  3. Covarrubias AJ et al. Nature Reviews Molecular Cell Biology. 2021;22:119-141.
    doi:10.1038/s41580-020-00313-x

Written by

Form Laboratories research team

Perth, Western Australia. We supply research-use-only reference material with lot-matched paperwork.

Written in-house
These articles are written and maintained by our own research team, not by a named clinician.
Built from the record
Every figure comes from published literature, listed in full above with a link to the original paper.
No use directions
We describe what the research measured. We never give dosing, preparation, or advice.

Form Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.

2026 Form Laboratories - Research use only - Perth WAPerth WA 6000 - lot-matched paperwork, dispatched Australia-wide via Australia Post or CouriersPlease